readthroughSign in
CompanyIVVDNasdaqNew Haven, CT

Invivyd, Inc.

Invivyd develops monoclonal antibodies against viral infectious diseases, beginning with SARS-CoV-2.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story